Company / Net Debt per Share
Zenas BioPharma, Inc. Net Debt per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.77
FY2025
5-year range
-$0.77 / -$0.77
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#60 of 82
Health Care
What the data says
At $-0.77, Zenas BioPharma, Inc.'s net debt per share ranks #23 of 82 in the Health Care sector.
Based on SEC 10-K filings.
-0.77 in FY2025.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#23 of 82 in Health CareTop 27% of 82This company -$0.77 Sector average $13.70
▼
-105.6% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.77 | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026